Rare diseases
Investigational molecules
Locations
Back to Slovakia231 clinical trials in Kosice, Slovakia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
SlovakiaStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
SlovakiaStudy on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination
SlovakiaStudy on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod
SlovakiaStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
SlovakiaStudy on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation
SlovakiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
SlovakiaStudy on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure
SlovakiaStudy of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients
SlovakiaStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
SlovakiaStudy on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)
SlovakiaStudy on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on chronic respiratory conditions, including studies evaluating new treatments for COPD and uncontrolled asthma. Trials are examining novel therapeutic approaches to improve patient outcomes and quality of life.
Research includes evaluation of medications like tezepelumab for COPD and AZD8630 for asthma control.
Comprehensive studies addressing cardiovascular health and metabolic conditions, from heart failure prevention to lipid disorders management.
Current trials are exploring innovative combinations of medications for cardiovascular risk reduction and metabolic control.
Advanced research into inflammatory and autoimmune disorders, including studies on Crohn's disease, ulcerative colitis, and Sjögren's syndrome.
Trials are evaluating novel biological treatments and targeted therapies for various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
